BINV - ETF AI Analysis
Top Page
Brandes International ETF (BINV)
Rating:57Neutral
Price Target:―
Positive Factors
Broad International Diversification
The fund spreads its investments across many countries, including the U.S., Europe, and Asia, which helps reduce the impact of problems in any single market.
Balanced Sector Mix
Holdings are spread across health care, consumer, industrial, technology, and other sectors, helping smooth out performance when one industry is struggling.
Several Strong Top Holdings
Some of the largest positions, such as Takeda Pharmaceutical, Carrefour, Astellas Pharma, and Ambev, have shown strong recent performance, supporting the fund’s overall results.
Negative Factors
High Expense Ratio
The fund’s expense ratio is relatively high for an ETF, which means more of your returns are used to cover fees each year.
Mixed Performance Among Top Holdings
Key positions like Sanofi, SAP, Henkel, and Heineken have shown weak recent performance, which can drag on the fund’s returns.
Short-Term Performance Bumps
While performance so far this year is positive, the fund has recently had a weak three-month stretch, showing that returns can be uneven over shorter periods.
BINV vs. SPDR S&P 500 ETF (SPY)
AUM488.62M
RegionGlobal
Expense Ratio0.70%
Beta0.62
IssuerBrandes
Inception DateOct 03, 2023
Dividend Yield2.18%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume53,583
30 Day Avg. Volume43,770
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
49.17Price Target Upside― Downside
Rating ConsensusHold
Number of Analyst Covering63
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BINV Summary
Brandes International ETF (BINV) is an actively managed fund that invests in a wide mix of companies outside the U.S., with a focus on “value” stocks—businesses the managers believe are currently priced lower than what they’re worth. It doesn’t track a set index, but spreads money across many countries and sectors, including well-known names like Sanofi and Alibaba. Investors might consider BINV for long-term growth and diversification beyond the U.S. market. A key risk is that international and value stocks can be out of favor for long periods, so the share price can rise and fall significantly over time.
How much will it cost me?The Brandes International ETF (BINV) has an expense ratio of 0.7%, which means you’ll pay $7 per year for every $1,000 invested. This is higher than average because it is actively managed, meaning experts are selecting stocks rather than following a passive index.
What would affect this ETF?The Brandes International ETF (BINV) could benefit from global economic recovery and increased consumer spending, particularly in sectors like Consumer Defensive and Health Care, which are heavily weighted in its portfolio. However, it may face challenges from rising interest rates or geopolitical tensions that could impact international markets and the performance of its top holdings, such as Sanofi and Alibaba. Additionally, regulatory changes in emerging markets could pose risks to some of its investments.
BINV Top 10 Holdings
BINV leans heavily into international value names, with a clear tilt toward European and Asian blue chips rather than U.S. giants. Recently, DHL and Richemont have been doing the heavy lifting, with rising momentum that helps offset softer spots elsewhere. On the other side, Alibaba has been dragging the fund, while SAP looks stuck in a rough patch despite solid business trends. Health care anchors like Sanofi and Takeda are more steady than spectacular, giving the ETF a defensive backbone within a broadly diversified global mix.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Sanofi | 3.00% | $14.47M | €89.40B | -12.06% | 75 Outperform | |
| SAP SE | 2.55% | $12.28M | $179.67B | -48.59% | 69 Neutral | |
| Alibaba | 2.42% | $11.64M | $256.89B | -7.18% | 68 Neutral | |
| Takeda Pharmaceutical Co | 2.33% | $11.21M | ¥7.82T | 12.26% | 66 Neutral | |
| Henkel AG & Co. KGaA | 2.29% | $11.05M | €27.78B | 7.70% | 73 Outperform | |
| ― | 2.27% | $10.91M | ― | ― | ― | |
| Compagnie Financiere Richemont SA | 2.07% | $9.97M | CHF107.76B | 23.72% | 78 Outperform | |
| Heineken Holding NV | 2.07% | $9.97M | €17.64B | -1.70% | 76 Outperform | |
| GlaxoSmithKline | 2.02% | $9.73M | $102.05B | 32.62% | 77 Outperform | |
| Fresenius Medical Care AG & Co. KGaA | 1.96% | $9.44M | €10.81B | -11.97% | 64 Neutral |
BINV Technical Analysis
Positive
―
Price Trends
42.67
Positive
42.56
Positive
40.95
Positive
Market Momentum
-0.04
Positive
51.47
Neutral
29.70
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BINV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 42.64, equal to the 50-day MA of 42.67, and equal to the 200-day MA of 40.95, indicating a bullish trend. The MACD of -0.04 indicates Positive momentum. The RSI at 51.47 is Neutral, neither overbought nor oversold. The STOCH value of 29.70 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BINV.
BINV Peer Comparison
Comparison Results
Performance Comparison
BINV
Brandes International ETF
42.73
7.22
20.33%
FPAG
FPA Global Equity ETF
―
―
―
MFSV
MFS Active Value ETF
―
―
―
GMOI
GMO International Value ETF
―
―
―
COPY
Tweedy Browne Insider + Value ETF Trust Units
―
―
―
CSTK
Invesco Comstock Contrarian Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents